DK1166788T3 - Lægemidler til ledsygdomme - Google Patents

Lægemidler til ledsygdomme

Info

Publication number
DK1166788T3
DK1166788T3 DK00908017.7T DK00908017T DK1166788T3 DK 1166788 T3 DK1166788 T3 DK 1166788T3 DK 00908017 T DK00908017 T DK 00908017T DK 1166788 T3 DK1166788 T3 DK 1166788T3
Authority
DK
Denmark
Prior art keywords
drugs
zinc
joint diseases
hyaluronic acid
complex
Prior art date
Application number
DK00908017.7T
Other languages
English (en)
Inventor
Isao Serizawa
Janos Illes
Erzsebet Neszmeli
Keisei Maekawa
Original Assignee
Takata Seiyaku Co Ltd
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takata Seiyaku Co Ltd, Richter Gedeon Nyrt filed Critical Takata Seiyaku Co Ltd
Application granted granted Critical
Publication of DK1166788T3 publication Critical patent/DK1166788T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK00908017.7T 1999-03-10 2000-03-10 Lægemidler til ledsygdomme DK1166788T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP06371899A JP2003089647A (ja) 1999-03-10 1999-03-10 関節性疾患治療剤
PCT/JP2000/001487 WO2000053194A1 (fr) 1999-03-10 2000-03-10 Medicaments contre les affections articulaires

Publications (1)

Publication Number Publication Date
DK1166788T3 true DK1166788T3 (da) 2010-08-23

Family

ID=13237463

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00908017.7T DK1166788T3 (da) 1999-03-10 2000-03-10 Lægemidler til ledsygdomme

Country Status (21)

Country Link
US (1) US6608043B1 (da)
EP (1) EP1166788B8 (da)
JP (1) JP2003089647A (da)
KR (1) KR100728096B1 (da)
CN (1) CN1165315C (da)
AT (1) ATE466584T1 (da)
AU (1) AU2942500A (da)
BG (1) BG65681B1 (da)
CA (1) CA2364451C (da)
CY (1) CY1109773T1 (da)
CZ (1) CZ301736B6 (da)
DE (1) DE60044341D1 (da)
DK (1) DK1166788T3 (da)
EA (1) EA005010B1 (da)
EE (1) EE04660B1 (da)
ES (1) ES2344677T3 (da)
PL (1) PL200848B1 (da)
PT (1) PT1166788E (da)
SK (1) SK287223B6 (da)
UA (1) UA72913C2 (da)
WO (1) WO2000053194A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0303779A2 (en) * 2003-11-20 2006-02-28 Richter Gedeon Vegyeszet Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
ITRM20030590A1 (it) * 2003-12-22 2005-06-23 Univ Siena Formulazione a base di polimetafosfati per la cura di artropatie microcristalline.
JPWO2005089800A1 (ja) * 2004-03-17 2008-01-31 株式会社ロコモジェン ｈｓＨＲＤ３を含む医薬組成物
US20070099867A1 (en) * 2005-05-24 2007-05-03 Glycoscience Laboratories, Inc. Pharmaceutical agent containing hyaluronan as an active ingredient
RU2342148C2 (ru) * 2005-09-26 2008-12-27 Гликосайенс Лабораториз, Инк. Фармацевтическое средство, содержащее гиалуронан в качестве активного ингредиента
JP2009091248A (ja) * 2006-01-17 2009-04-30 Toshitsu Kagaku Kenkyusho:Kk 外傷性神経障害および／または運動機能障害の治療薬
EP1994934A4 (en) 2006-12-05 2010-03-10 Glycoscience Lab Inc THERAPEUTIC AGENT AGAINST DEGENERATIVE ARTHRITIS
FR2927255B1 (fr) * 2008-02-07 2011-08-12 Keysan Consulting Produits injectables biocompatibles a liberation de zinc et/ou de sel de saccharide sous forme de zinc et leurs utilisations.
US8462765B2 (en) * 2008-08-20 2013-06-11 Qualcomm Incorporated Method and apparatus to perform ranging operations for wireless stations
JP5587637B2 (ja) * 2009-04-10 2014-09-10 生化学工業株式会社 マトリックスメタロプロテアーゼ阻害剤及びその用途
HUP0900717A3 (en) 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
ES2665254T3 (es) * 2011-07-12 2018-04-25 Holy Stone Healthcare Co., Ltd. Composiciones que comprenden ácido hialurónico para tratamiento y prevención de enfermedades relacionadas con las mucosas
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1291123C (en) * 1986-03-14 1991-10-22 Abraham Nimrod Heavy metal salts of hyaluronic acid useful as antimicrobial agents
US4746504A (en) * 1986-03-14 1988-05-24 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid and their use as antimicrobial agents
AU604542B2 (en) * 1987-03-19 1990-12-20 Arthropharm Pty Ltd Polysulphated polysaccharide complexes
AU616502B2 (en) * 1988-04-22 1991-10-31 Medvet Science Pty. Ltd. Treatment of inflammatory disorders in humans
HU203372B (en) 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
CZ202591A3 (cs) * 1991-07-02 1993-01-13 Hypro Vyzkum Prostředek pro prevenci dekubitft a topickou terapii kožních lézt
US5744442A (en) * 1992-08-26 1998-04-28 Bristol Meyers Squibb Company Regulation of cellular invasiveness
IT1281877B1 (it) * 1995-05-10 1998-03-03 Fidia Advanced Biopolymers Srl Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici
IT1288290B1 (it) * 1996-06-21 1998-09-11 Fidia Spa In Amministrazione S Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie
EP0834319A1 (en) * 1996-10-07 1998-04-08 Kartar Dr. Lalvani Mineral and vitamin combinations in arthritic pain

Also Published As

Publication number Publication date
KR100728096B1 (ko) 2007-06-14
EP1166788A1 (en) 2002-01-02
SK287223B6 (sk) 2010-03-08
CN1165315C (zh) 2004-09-08
KR20010108343A (ko) 2001-12-07
PL200848B1 (pl) 2009-02-27
EP1166788B1 (en) 2010-05-05
BG65681B1 (bg) 2009-06-30
PL350289A1 (en) 2002-12-02
PT1166788E (pt) 2010-06-25
EP1166788B8 (en) 2010-06-16
JP2003089647A (ja) 2003-03-28
AU2942500A (en) 2000-09-28
CZ20013110A3 (cs) 2002-01-16
EA200100963A1 (ru) 2002-02-28
ES2344677T3 (es) 2010-09-03
CA2364451C (en) 2011-08-02
CZ301736B6 (cs) 2010-06-09
ATE466584T1 (de) 2010-05-15
EE200100478A (et) 2003-02-17
CA2364451A1 (en) 2000-09-14
EA005010B1 (ru) 2004-10-28
DE60044341D1 (de) 2010-06-17
UA72913C2 (en) 2005-05-16
CN1343122A (zh) 2002-04-03
US6608043B1 (en) 2003-08-19
WO2000053194A1 (fr) 2000-09-14
BG105885A (en) 2002-06-28
SK12502001A3 (sk) 2002-02-05
EE04660B1 (et) 2006-08-15
EP1166788A4 (en) 2007-10-10
CY1109773T1 (el) 2014-09-10

Similar Documents

Publication Publication Date Title
CY1109773T1 (el) Φαρμακα για ασθενειες των αρθρωσεων
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
ATE514418T1 (de) Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
DE60041761D1 (de) Tribonektine
DE60330187D1 (de) Fluoralkoxy-substituierte 1, 3-dihydro-isoindolyl-verbindungen und ihre pharmazeutischen verwendungen
BR0313059B8 (pt) composto, e, composição farmacêutica
NO20035025L (no) Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet.
BR0313239A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de doenças
DE60313004D1 (de) Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
IL163951A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
ITMI20022394A1 (it) Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
TW200505408A (en) Agent for preventing and/or treating tissue disruption-accompanied diseases
BR0010560A (pt) 3-piridil-4-arilpirrois substituìdos e métodos terapêuticos e profiláticos relacionados
WO2006005142A3 (en) Mono- and polycyclic compounds with therapeutic activity, pharmaceutical compositions including them and intermediates for making them
NO20031650D0 (no) Nye legemidler for leversykdommer
EP1563836A4 (en) ACTIVE SUBSTANCE FOR INHIBITING MATRIX METALOPROTEASE-9 PRODUCTION
TR200102583T2 (tr) Alt idrar yolları semptomlarının tedavisine yönelik farmasötik bileşim.
WO2002085368A3 (en) Use of radical scavenging compounds for treatment and prevention of no-dependent microcirculation disorders
PE20030732A1 (es) Empleo de alquilfosfocolinas en el tratamiento preventivo de enfermedades causadas por protozoarios
DE69932434D1 (de) Prophylaxe und Behandlung von autoimmunen Entmyelinisierungserkrankungen durch Fas-antagonisten
AU2003294834A1 (en) Anthranilic acid amide derivatives and their pharmaceutical use
EA200400382A1 (ru) Применение специфической дозы фондапаринукса натрия для лечения окс